A detailed history of Oppenheimer & CO Inc transactions in Mckesson Corp stock. As of the latest transaction made, Oppenheimer & CO Inc holds 3,893 shares of MCK stock, worth $2.05 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,893
Previous 3,905 0.31%
Holding current value
$2.05 Million
Previous $2.28 Million 15.66%
% of portfolio
0.03%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$479.06 - $630.38 $5,748 - $7,564
-12 Reduced 0.31%
3,893 $1.92 Million
Q2 2024

Aug 07, 2024

BUY
$518.81 - $607.81 $120,882 - $141,619
233 Added 6.35%
3,905 $2.28 Million
Q1 2024

May 06, 2024

BUY
$473.42 - $539.26 $1.17 Million - $1.33 Million
2,473 Added 206.26%
3,672 $1.97 Million
Q4 2023

Feb 13, 2024

BUY
$437.42 - $470.64 $49,865 - $53,652
114 Added 10.51%
1,199 $555,000
Q3 2023

Nov 07, 2023

SELL
$402.4 - $446.42 $23,741 - $26,338
-59 Reduced 5.16%
1,085 $471,000
Q2 2023

Aug 02, 2023

SELL
$354.01 - $427.31 $220,902 - $266,641
-624 Reduced 35.29%
1,144 $488,000
Q1 2023

May 10, 2023

BUY
$335.35 - $386.06 $18,779 - $21,619
56 Added 3.27%
1,768 $629,000
Q4 2022

Feb 07, 2023

BUY
$346.68 - $397.58 $46,108 - $52,878
133 Added 8.42%
1,712 $642,000
Q3 2022

Nov 14, 2022

BUY
$321.25 - $373.84 $141,028 - $164,115
439 Added 38.51%
1,579 $537,000
Q2 2022

Aug 08, 2022

SELL
$300.57 - $336.42 $18,034 - $20,185
-60 Reduced 5.0%
1,140 $372,000
Q1 2022

May 12, 2022

SELL
$244.61 - $310.48 $689,555 - $875,243
-2,819 Reduced 70.14%
1,200 $367,000
Q4 2021

Feb 02, 2022

SELL
$198.21 - $248.9 $44,002 - $55,255
-222 Reduced 5.23%
4,019 $999,000
Q3 2021

Nov 12, 2021

SELL
$188.42 - $208.66 $432,047 - $478,457
-2,293 Reduced 35.09%
4,241 $846,000
Q2 2021

Aug 03, 2021

BUY
$184.89 - $202.68 $42,894 - $47,021
232 Added 3.68%
6,534 $1.25 Million
Q1 2021

May 10, 2021

BUY
$169.52 - $196.53 $301,915 - $350,019
1,781 Added 39.39%
6,302 $1.23 Million
Q4 2020

Feb 11, 2021

BUY
$143.79 - $183.66 $89,149 - $113,869
620 Added 15.89%
4,521 $786,000
Q3 2020

Nov 13, 2020

SELL
$140.89 - $159.9 $10,989 - $12,472
-78 Reduced 1.96%
3,901 $580,000
Q2 2020

Aug 11, 2020

BUY
$125.49 - $164.68 $27,607 - $36,229
220 Added 5.85%
3,979 $611,000
Q1 2020

May 08, 2020

BUY
$115.75 - $170.96 $135,774 - $200,536
1,173 Added 45.36%
3,759 $508,000
Q4 2019

Feb 07, 2020

SELL
$130.23 - $153.27 $9,767 - $11,495
-75 Reduced 2.82%
2,586 $358,000
Q3 2019

Oct 31, 2019

BUY
$134.24 - $148.53 $2,550 - $2,822
19 Added 0.72%
2,661 $364,000
Q2 2019

Aug 09, 2019

BUY
$112.47 - $134.93 $39,364 - $47,225
350 Added 15.27%
2,642 $355,000
Q1 2019

Apr 24, 2019

BUY
$111.86 - $136.3 $13,311 - $16,219
119 Added 5.48%
2,292 $268,000
Q4 2018

Jan 29, 2019

SELL
$108.23 - $136.84 $19,914 - $25,178
-184 Reduced 7.81%
2,173 $240,000
Q3 2018

Oct 26, 2018

BUY
$123.14 - $138.52 $91,739 - $103,197
745 Added 46.22%
2,357 $313,000
Q2 2018

Aug 10, 2018

BUY
$133.4 - $158.13 $215,040 - $254,905
1,612 New
1,612 $215,000
Q1 2018

May 01, 2018

SELL
$138.75 - $176.72 $445,526 - $567,447
-3,211 Closed
0 $0
Q4 2017

Feb 07, 2018

SELL
$135.02 - $162.6 $41,586 - $50,080
-308 Reduced 8.75%
3,211 $501,000
Q3 2017

Nov 09, 2017

BUY
$146.0 - $161.87 $513,774 - $569,620
3,519
3,519 $541,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $75.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.